Saturday, 31 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 17, 2026

Stock market today: Dow, S&P 500, Nasdaq edge higher in volatile trading as Wall Street assesses AI fears

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq edge higher in volatile trading as Wall Street assesses AI fears US stocks edged higher Tuesday in volatile trading as Wall Street continued assessing the AI jitters that have hammered markets in recent weeks…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • If US negotiations aim to eliminate Iran's nuclear energy, there is no room for negotiation; determining the outcome of negotiations in advance is wrong and foolish

    80% confidence
  • AI is fundamentally increasing electricity demand across the technology sector, and geothermal power is uniquely positioned to deliver reliable, carbon-free power to support that growth

    80% confidence
  • The Netflix merger is in the best interests of WBD shareholders due to the tremendous value it provides with a clear path to achieve regulatory approval

    80% confidence
  • Nvidia has key investor topics ahead of earnings: higher component costs impacting expected mid-70s gross margins, updates on Anthropic/OpenAI investments, inference competition, and impact of Groq licensing agreement

    80% confidence
  • Corporate profits are rising while labor income falls, fueling a K-shaped economy; the split is reinforced by rallies in financial and real assets concentrated among higher- and middle-income households

    80% confidence
  • Despite short-term softness, the structural drivers supporting gold remain firmly in place, driven by central bank buying, geopolitical fragmentation, and portfolio diversification

    80% confidence
  • Weak consumer sentiment, heightened uncertainty, and significant volatility weighed on category growth and impacted consumer purchase patterns, contributing to lowered 2026 outlook

    80% confidence
  • Wedbush maintained an Outperform rating and $350 price target on Apple

    80% confidence
  • It remains to be seen whether wages and salaries recoup some of their lost ground relative to corporate profits; higher profits relative to wages are yet another driver of a K-shaped economy

    80% confidence
  • The recent worry and sell-off in Apple's shares is unwarranted; Apple's AI strategy and advanced AI features remain on track for summer release

    80% confidence
  • Iran and the US reached a general agreement on a set of guiding principles for a potential nuclear deal

    80% confidence
  • While the company is making meaningful progress in strengthening its remarkability for long-term sustainable growth, progress has come amid a more challenging backdrop

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com